FDA issues warning letters for CGMP violations, marketing devices for unintended uses
Regulatory NewsFerdous Al-Faruque
Medical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning lettersRegulatory NewsFerdous Al-FaruqueMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning letters